Axsome Therapeutics Wins FDA Nod for Auvelity in Alzheimer’s Agitation, Launch Set for June

May 3, 2026

alzheimers-dementia

Axsome Therapeutics Wins FDA Nod for Auvelity in Alzheimer’s Agitation, Launch Set for June

ONLY AVAILABLE IN PAID PLANS.

Originally reported by thelincolnianonline. Read more

Source: https://www.thelincolnianonline.com/2026/05/01/axsome-therapeutics-wins-fda-nod-for-auvelity-in-alzheimers-agitation-launch-set-for-june.html